A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05039931 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped leading entity of the clinical trial was replaced, and no patients were enrolled.

Conditions

Interventions

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators